Due to potential COVID exposure and the continued safety of our employees, Good Days will be operating with limited staffing through August 9th, 2021. We will be assisting patients, providers and pharmacies electronically. If you would like to enroll for assistance, please visit https://www.mygooddays.org/apply. To connect with a Care Navigator, please contact us via email at admin@mygooddays.org or through chat by visiting https://www.mygooddays.org. We appreciate your patience and look forward to continuing to serve you.

 
Diseases Covered

Myeloproliferative Diseases

Includes: Hypereosinophilic Syndrome, Myelofibrosis, Essential Thrombocytosis, Polycythemia vera
All pictures shown are used for illustrative purposes only.

Program Status

open

Apply Now

We encourage you to apply for assistance; see the qualifications below.
 

Assistance Amount

$ 6,500

Ask your Good Days Patient Care Navigator for more information.

Eligibility Criteria

  • Patient must be diagnosed with a covered disease and program must be accepting enrollments
  • Patient must have a valid Social Security number to apply for assistance and receive treatment in the United States
  • Patient must be seeking assistance for a prescribed medication that is FDA approved to treat the covered diagnosis
  • Patient is required to have valid Medicare or Military insurance coverage
  • Patient income level must be at or below 500% of the Federal Poverty Level (FPL)

Apply Now

  • Agrylin
  • Anagrelide
  • Droxia/Hydrea
  • Gleevec
  • Hydrea
  • Hydroxyurea
  • Imatinib Mesylate
  • Inrebic
  • Jakafi
  • Promacta

Chronic myeloproliferative neoplasms are diseases in which the bone marrow makes too many red blood cells, platelets, or certain white blood cells. (Source: NIH; National Cancer Institute)

Medications Covered

  • Agrylin
  • Anagrelide
  • Droxia/Hydrea
  • Gleevec
  • Hydrea
  • Hydroxyurea
  • Imatinib Mesylate
  • Inrebic
  • Jakafi
  • Promacta

Disease Description

Chronic myeloproliferative neoplasms are diseases in which the bone marrow makes too many red blood cells, platelets, or certain white blood cells. (Source: NIH; National Cancer Institute)

Apply For Assistance

Speeding your treatment is important to us.

Get Our Newsletter

You're not alone. The Good Days newsletter keeps you up-to-date.